These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32466973)

  • 21. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.
    Gaedigk A; Gotschall RR; Forbes NS; Simon SD; Kearns GL; Leeder JS
    Pharmacogenetics; 1999 Dec; 9(6):669-82. PubMed ID: 10634130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance of response clinical trial.
    Fijal BA; Guo Y; Li SG; Ahl J; Goto T; Tanaka Y; Nisenbaum LK; Upadhyaya HP
    J Clin Pharmacol; 2015 Oct; 55(10):1167-74. PubMed ID: 25919121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia.
    Griese EU; Ilett KF; Kitteringham NR; Eichelbaum M; Powell H; Spargo RM; LeSouef PN; Musk AW; Minchin RF
    Pharmacogenetics; 2001 Feb; 11(1):69-76. PubMed ID: 11207032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 2D6 polymorphisms and predicted opioid metabolism in African American children with sickle cell disease.
    Yee MM; Josephson C; Hill CE; Harrington R; Castillejo MI; Ramjit R; Osunkwo I
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):e301-5. PubMed ID: 23619115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.
    Wuttke H; Rau T; Heide R; Bergmann K; Böhm M; Weil J; Werner D; Eschenhagen T
    Clin Pharmacol Ther; 2002 Oct; 72(4):429-37. PubMed ID: 12386645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
    Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
    Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP2D6 genotyping in patients on psychoactive drug therapy.
    Topić E; Stefanović M; Ivanisević AM; Blazinić F; Culav J; Skocilić Z
    Clin Chem Lab Med; 2000 Sep; 38(9):921-7. PubMed ID: 11097351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
    Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
    Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone.
    Hongkaew Y; Gaedigk A; Wilffert B; Ngamsamut N; Kittitharaphan W; Limsila P; Sukasem C
    Sci Rep; 2021 Feb; 11(1):4158. PubMed ID: 33603025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of human cytochrome P450 CYP2D6 gene.
    Steen VM; Molven A; Aarskog NK; Gulbrandsen AK
    Hum Mol Genet; 1995 Dec; 4(12):2251-7. PubMed ID: 8634695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and characterization of the CYP2D6*9x2 gene duplication in two Spanish populations: resolution of AmpliChip CYP450 test no-calls.
    Gaedigk A; Hernandez J; García-Solaesa V; Sánchez S; Isidoro-García M
    Pharmacogenomics; 2011 Nov; 12(11):1617-22. PubMed ID: 22044417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.
    Zanger UM; Raimundo S; Eichelbaum M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):23-37. PubMed ID: 14618296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status.
    Barclay ML; Sawyers SM; Begg EJ; Zhang M; Roberts RL; Kennedy MA; Elliott JM
    Pharmacogenetics; 2003 Oct; 13(10):627-32. PubMed ID: 14515061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
    Buzková H; Pechandová K; Slanar O; Perlík F
    Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians.
    Kohlrausch FB; Gama CS; Lobato MI; Belmonte-de-Abreu P; Gesteira A; Barros F; Carracedo A; Hutz MH
    Pharmacogenomics; 2009 Sep; 10(9):1457-66. PubMed ID: 19761369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokinetics.
    Furman KD; Grimm DR; Mueller T; Holley-Shanks RR; Bertz RJ; Williams LA; Spear BB; Katz DA
    Pharmacogenetics; 2004 May; 14(5):279-84. PubMed ID: 15115913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CYP4502D6 *4 and *6 alleles are the molecular genetic markers for drug response: implications in colchicine non-responder FMF patients.
    Yalcıntepe S; Ozdemır O; Sılan C; Ozen F; Uludag A; Candan F; Sılan F
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):281-6. PubMed ID: 25645282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.
    Bertilsson L; Dahl ML; Dalén P; Al-Shurbaji A
    Br J Clin Pharmacol; 2002 Feb; 53(2):111-22. PubMed ID: 11851634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6.
    Qiao W; Yang Y; Sebra R; Mendiratta G; Gaedigk A; Desnick RJ; Scott SA
    Hum Mutat; 2016 Mar; 37(3):315-23. PubMed ID: 26602992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.